--- title: "Skyward Specialty Insurance (SKWD) Q4 Earnings: What To Expect" description: "Skyward Specialty Insurance (SKWD) will report Q4 earnings on Monday. Last quarter, it exceeded revenue expectations with $382.5 million, a 27.1% year-on-year increase. Analysts expect a 25% revenue g" type: "news" locale: "en" url: "https://longbridge.com/en/news/276525102.md" published_at: "2026-02-22T03:06:59.000Z" --- # Skyward Specialty Insurance (SKWD) Q4 Earnings: What To Expect > Skyward Specialty Insurance (SKWD) will report Q4 earnings on Monday. Last quarter, it exceeded revenue expectations with $382.5 million, a 27.1% year-on-year increase. Analysts expect a 25% revenue growth this quarter. Despite past misses on estimates, peers like First American Financial and Stewart Information Services have shown positive results. Skyward's stock is up 4.4% recently, with an average analyst price target of $63.80 against a current price of $47.01. Specialty insurance provider Skyward Specialty Insurance will be reporting earnings this Monday after the bell. Here’s what you need to know. Skyward Specialty Insurance beat analysts’ revenue expectations last quarter, reporting revenues of $382.5 million, up 27.1% year on year. It was a stunning quarter for the company, with a solid beat of analysts’ net premiums earned estimates and an impressive beat of analysts’ revenue estimates. Is Skyward Specialty Insurance a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, the market is expecting Skyward Specialty Insurance’s revenue to grow 25% year on year, improving from the 23.6% increase it recorded in the same quarter last year. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Skyward Specialty Insurance has missed Wall Street’s revenue estimates multiple times over the last two years. Looking at Skyward Specialty Insurance’s peers in the property & casualty insurance segment, some have already reported their Q4 results, giving us a hint as to what we can expect. First American Financial delivered year-on-year revenue growth of 21.6%, beating analysts’ expectations by 15.2%, and Stewart Information Services reported revenues up 19.6%, topping estimates by 2.5%. First American Financial traded up 2.8% following the results while Stewart Information Services was also up 2.9%. Read our full analysis of First American Financial’s results here and Stewart Information Services’s results here. Investors in the property & casualty insurance segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Skyward Specialty Insurance is up 4.4% during the same time and is heading into earnings with an average analyst price target of $63.80 (compared to the current share price of $47.01). ### Related Stocks - [SKWD.US - Skyward Specialty Insurance](https://longbridge.com/en/quote/SKWD.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Skyward Specialty 的盈利展望 | Skyward Specialty(纳斯达克代码:SKWD)将于 2026 年 2 月 23 日公布季度财报,分析师预测每股收益(EPS)为 0.98 美元。投资者热切期待此次公告,以获取潜在的积极指引。该公司此前超出了每股收益的预期,导致 | [Link](https://longbridge.com/en/news/276467310.md) | | Skyward Specialty Insurance Group 的首席产品官 Thomas N. Schmitt 报告了普通股的出售情况 | Skyward Specialty Insurance Group Inc. 的首席人事官 Thomas N. Schmitt 报告了该公司普通股的处置。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成 | [Link](https://longbridge.com/en/news/275510045.md) | | CervoMed 的 Neflamapimod 被选入英国专家 ALS 平台 | CervoMed Inc:CERVOMED 的 NEFLAMAPIMOD 被选入英国专家 ALS 平台,该平台旨在优先考虑有前景的肌萎缩侧索硬化症治疗方案。CERVOMED INC - 首位 ALS 患者预计将在 2026 年底前接受治疗。 | [Link](https://longbridge.com/en/news/276219812.md) | | 新泽西州共同养老金基金 D 购买了 15,186 股 FormFactor 公司的股票,股票代码为$FORM | 新泽西州公共养老金基金 D 在第三季度将其在 FormFactor, Inc.的持股增加了 24.8%,增持了 15,186 股,总持股达到 76,376 股,价值约为 278 万美元。其他机构投资者也显著增加了他们的持仓。分析师对 For | [Link](https://longbridge.com/en/news/276513853.md) | | Technoprobe 宣布对前员工提起法律诉讼 | Technoprobe SpA:TECHNOPROBE S.P.A. 宣布对前员工提起法律诉讼诉讼已在加利福尼亚中区美国地方法院提交指控包括违反数字千年版权法指控商标侵权和联邦不正当竞争指控不正当竞争和违反合同 | [Link](https://longbridge.com/en/news/276360593.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.